Janet Shin, Ph.D.
Affiliations: | 2012 | Pharmaceutical Economics and Policy | University of Southern California, Los Angeles, CA, United States |
Area:
Health Care Management, Pharmacy, General EconomicsGoogle:
"Janet Shin"Parents
Sign in to add mentor| Jeffrey McCombs | grad student | 2012 | USC | |
| (Understanding primary nonadherence to medications and its associated healthcare outcomes: A retrospective analysis of electronic medical records in an integrated healthcare setting.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cheetham TC, Niu F, Green K, et al. (2013) Primary nonadherence to statin medications in a managed care organization. Journal of Managed Care Pharmacy : Jmcp. 19: 367-73 |
| Shin J, McCombs JS, Sanchez RJ, et al. (2012) Primary nonadherence to medications in an integrated healthcare setting. The American Journal of Managed Care. 18: 426-34 |
| McCombs JS, Shin J, Hines P, et al. (2012) Tu1014 Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV): an Update Gastroenterology. 142: S-1011 |
| Shin J, Mccombs J, Udall M, et al. (2012) PCV71 Primary Nonadherence to Cholesterol Medications and Associated Health Care Outcomes Value in Health. 15: A125 |
| Shin J, McCombs J, Sanchez R, et al. (2012) PHP20 Factors Associated With Primary Nonadherence to Chronic and Acute Medications Value in Health. 15: A16 |
| McCombs JS, Yuan Y, Shin J, et al. (2011) Economic burden associated with patients diagnosed with hepatitis C. Clinical Therapeutics. 33: 1268-80 |
| Shin J, Cheetham TC, Wong L, et al. (2011) The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. Journal of the American Academy of Dermatology. 65: 1117-25 |
| McCombs JS, Shin J, Hines P, et al. (2011) Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV) Gastroenterology. 140: S-936 |
| McCombs JS, Shin J, Hines P, et al. (2011) Impact of Newly Diagnosed Hepatitis C Infections on Health Care Costs Gastroenterology. 140: S-936 |
| McCombs J, Shin J, Hines P, et al. (2011) PIN44 REAL-WORLD EVALUATION OF THE ECONOMIC IMPACT OF DURATION OF DRUG THERAPY IN THE TREATMENT OF HEPATITIS C VIRUS (HCV) Value in Health. 14: A121 |